In this interview, CellVoyant founder and CEO Rafael Carazo Salas explores how AI, live-cell imaging, and stem cell technologies are converging to transform cell therapy development. He shares insights on the challenges of scaling…
In this interview, CellVoyant founder and CEO Rafael Carazo Salas explores how AI, live-cell imaging, and stem cell technologies are converging to transform cell therapy development. He shares insights on the challenges of scaling…